REFERENCES
B. J. Aungst, N. J. Rogers, and E. Shefter. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J. Pharmacol. Exp. Ther. 244:23–27 (1988).
B. J. Aungst and N. J. Rogers. Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery. Pharm. Res. 5:305–308 (1988).
I. Morishita, M. Morishita, K. Takayama, Y. Machida, and T. Nagai. Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. Int. J. Pharm. 78:9–16 (1992).
Y. Li, Z. Shao, and A. K. Mitra. Effect of a conjugated bile salt on the pulmonary absorption of insulin in rats. Eur. J. Pharm. Biopharm. 39:216–221 (1993).
Z. Shao, Y. Li, R. Krishnamoorthy, T. Chermak, and A. K. Mitra. Differential effects of anionic, cationic, nonionic, and physiologic surfactants on the dissociation, α-chymotryptic degradation, and enteral absorption of insulin hexamers. Pharm. Res. 10:243–251 (1993).
W. A. Ritschel and G. B. Ritschel. Rectal administration of insulin. In B. Glas and C. J. de Blaey (eds.), Rectal Therapy, J. R. Prous Publishers, Spain, 1984, pp. 67–84.
F.-Y. Liu, Z. Shao, D. O. Kildsig, and A. K. Mitra. Pulmonary delivery of free and liposomal insulin. Pharm. Res. 10:228–232 (1993).
S. Hirai, T. Yashiki, and H. Mima. Effect of surfactants on the nasal absorption of insulin in rats. Int. J. Pharm. 9:165–172 (1981).
S. Hirai, T. Ikenaga, and T. Metsuzawa. Nasal absorption of insulin in dogs. Diabetes, 27:296–299 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, Y., Mitra, A.K. A Simple Method of Correlating Pharmacodynamic Equivalence with Absolute Bioavailability Following Noninvasive Delivery of Insulin. Pharm Res 11, 1505–1508 (1994). https://doi.org/10.1023/A:1018972712870
Issue Date:
DOI: https://doi.org/10.1023/A:1018972712870